21 - 30 from 150 .
In "Life / Health"
LONDON — Children's eyesight is steadily getting worse with one in three now short-sighted or unable to see things in the distance clearly, a global analysis suggests.The researchers say Covid lockdowns had a negative impact on eyesight as children spent more time on screens and less time outdoors.Short-sightedness, or myopia, is a growing global health concern that is set to affect millions more children by 2050, the study warns.The highest rates are in Asia - 85% of children in Japan and 73% in South Korea are short-sighted with more than 40% affected in China and Russia.Paraguay and Uganda, at about 1%, had some of the lowest levels of myopia, with the UK, Ireland and the US all about 15%.The study, published in the British Journal of Ophthalmology, looked at research involving...
September 25, 2024
One in three children are short-sighted, study suggests
September 17, 2024
Superbug crisis could get worse, killing nearly 40 million people by 2050: Study
LONDON — A boy with severe epilepsy has become the first patient in the world to trial a new device fitted in their skull to control seizures.The neurostimulator, which sends electrical signals deep into his brain, has reduced Oran Knowlson’s daytime seizures by 80%.His mother, Justine, told the BBC he was happier and had a “much better quality of life”.The surgery was carried out in October as part of a trial at Great Ormond Street Hospital in London when Oran, who is now 13, was 12.Oran, from Somerset, has Lennox-Gastaut syndrome, a treatment-resistant form of epilepsy that he developed at the age of three.Since then he has suffered several daily seizures ranging from two dozen to hundreds.When we first spoke to Oran’s mum last autumn, prior to surgery, she explained how...
June 24, 2024
World's first epilepsy device fitted in UK boy's skull
VIENNA — Gentle shockwaves could regenerate the heart tissue of patients after bypass surgery, research suggests.A study of 63 people in Austria found those given the new treatment could walk further — and their hearts could pump more blood.“For the first time, we are seeing the heart muscle regenerate in a clinical setting, which could help millions of people,” Prof Johannes Holfeld, from Innsbruck Medical University, said.Larger trials of the device, dubbed a "space hairdryer" by researchers, are now planned to try to replicate the results in a wider group of patients.Every year, 18 million people around the world die from heart disease or other cardiovascular complications, according to the World Health Organization.Risk factors include high blood pressure and an...
June 20, 2024
‘Space hairdryer’ regenerates heart tissue in study
March 20, 2024
Intermittent fasting: Your heart, your health, your waistline
LONDON — The anti-anxiety drug has been linked to fatalities in the UK, leading people taking the drug to come forward about their debilitating side effects.The first time Jade had a panic attack, she called an ambulance. Terrified and feeling as though her world had suddenly tilted, she’d recently stopped taking pregabalin, a drug prescribed to her for anxiety.Two years later, she is still trying to wean herself off it.“If I miss a dose I have trouble breathing, depersonalization, panic attacks, extreme body restlessness, feeling as though I am going to pass out,” the 29-year-old told Euronews Health.“I don’t think doctors realise the severity of it.”The drug has been prescribed to more than 8 million people in the UK, according to a study.Over the last five years in...
March 07, 2024
Anti-anxiety drug Pregabalin causes concern in the UK
January 17, 2024
Exciting new cancer drug kinder than chemotherapy
November 10, 2023
US veteran gets world's first eye transplant
November 07, 2023
Animal-to-human infections could cause 12 times more deaths by 2050, study says
MUMBAI — Affan, seven, and Erhan, five, have Spinal Muscular Atrophy (SMA) — a rare genetic disorder that causes muscle deterioration and affects breathing. Physiotherapy appointments alone cost the family 40,000 rupees ($480; £395) a month, and their sons need constant care as they cannot sit, stand or walk independently."We want to try gene therapy for our sons, but one dose alone costs around 175m rupees ($2.1m; £1.7m). We simply can't afford it," says Zeba Gufran, their mother.Zolgensma gene therapy, which the Gufrans want to try, is one of the most expensive drugs in the world. It is given as a one-time dose, usually to children under two — but the Gufrans are desperate and hope for a miracle.Like them, many parents in India cannot afford to buy Zolgensma and...
November 06, 2023
Spinal Muscular Atrophy: Indians who need $2.1m drug to fight a rare disease
